The global stem cell therapy market size was US$ 188 million in 2021. The global stem cell therapy market size is forecast to reach US$ 899.66 million by 2030, growing at a compound annual growth rate (CAGR) of 19% during the forecast period from 2022 to 2030.
Humans and animals alike possess stem cells, which are the most valuable cells in the body. In medicine and surgery, stem cells can proliferate and can develop into nearly any type of cell in the body. There are two types of stem cells: adult stem cells and embryonic stem cells. The stem cells derived from human embryos are called embryonic stem cells (ESCs). They can develop into almost any type of cell in the body because they are pluripotent. Regenerative medicine or centerpiece therapy is other names for stem cell therapy. Medications that regenerate or replace damaged or dead cells have the ability to regenerate cells.
Factors Influencing Market Growth
Market growth is primarily due to factors such as increased stem cell research and the approval of GMP-certified facilities to manufacture stem cells.
The growing popularity of Induced pluripotent stem cells (iPSCs) as an alternative to embryonic stem cells (ESCs) and the demand for cell and gene therapies are forecast to boost this market's growth in the future.
There are several ethical issues associated with the use of stem cells since they are the result of destroying human embryos. Globally, concerns related to embryonic stem cells for developing stem cell therapy may slow down the global market growth.
Impact Analysis of COVID-19
The COVID-19 pandemic has negatively impacted the global stem cell therapy market. Earlier measures included social distancing, remote working, and the closure of commercial activities, resulting in operational challenges and supply chain disruption. As a result, the revenue of the market declined. Thus, affecting the global market.
Regional Insights
North America dominates the stem cell market, with the United States contributing the most to the market. North America and Canada have well-developed healthcare systems. They also provide opportunities for researchers and innovators. An increase in cancer cases is providing opportunities for market players. In order to introduce new stem cell therapies on the market, major market players focus on R&D.
Leading Competitors
The leading prominent companies profiled in the global stem cell therapy market are:
Scope of the Report
The global stem cell therapy market segmentation focuses on Cell Source, Type, Therapeutic Application, and Region.
Segmentation based on Cell Source
Segmentation based on Type
Segmentation based on Therapeutic Application
Segmentation based on Region
Table of Content
1 INTRODUCTION OF GLOBAL STEM CELL THERAPY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL STEM CELL THERAPY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE
5.1 OVERVIEW
5.2 Adipose tissue-derived MSCs (mesenchymal stem cells),
5.3 Bone marrow-derived MSCs,
5.4 Placental/umbilical cord-derived MSCs, and
5.5 Other Cell Sources
6 GLOBAL STEM CELL THERAPY MARKET, BY TYPE
6.1 OVERVIEW
6.2 Allogeneic Stem Cell Therapy
6.3 Autologous Stem Cell Therapy
7 GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION
7.1 OVERVIEW
7.2 Musculoskeletal Disorders
7.3 Wounds & Injuries
7.4 Cardiovascular Diseases
7.5 Surgeries
7.6 Inflammatory & Autoimmune Diseases
7.7 Neurological Disorders
7.8 Other Therapeutic Applications
8 MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1THE UK
8.3.2.2GERMANY
8.3.2.3FRANCE
8.3.2.4ITALY
8.3.2.5SPAIN
8.3.2.6REST OF WESTERN EUROPE
8.3.3EASTERN EUROPE
8.3.3.1POLAND
8.3.3.2RUSSIA
8.3.3.3REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL STEM CELL THERAPY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 Smith & Nephew plc
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 MEDIPOST
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 Anterogen CO. Limited
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 CORESTEM, Incorporated
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 PHARMICELL Co., Limited
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 NuVasive
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 RTI Surgical
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 AlloSource
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 JCR Pharmaceuticals
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 Takeda Pharmaceutical Company
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved